| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $9.16M | $9.11M | $9.90M | $8.83M | – | – |
| Cost of Revenue | $4.43M | $5.30M | $10.33M | $20.68M | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | $2.66M | $2.97M | $4.35M | $5.18M | – | – |
| SG&A | $8.18M | $9.78M | $17.25M | $12.70M | – | – |
| Operating Income | -$6.77M | -$10.40M | -$31.67M | -$36.46M | -$8.01M | -$233.25K |
| Interest Expense | – | – | – | – | – | – |
| Tax Expense | – | – | – | – | – | – |
| Net Income | -$14.62M | -$25.62M | -$34.28M | -$62.03M | -$4.63M | -$229.23K |
| EPS (basic) | -1.2800 | -51.8400 | -2.0500 | -128.5200 | – | – |
| EPS (diluted) | -1.2800 | -51.8400 | -2.0500 | -128.5200 | – | – |
| Shares (diluted) | $11.45M | $494.28K | $16.73M | $482.68K | – | – |